2018-2023 Global Pituitary cancer Market Report (Status and Outlook)
![](/report_cover/10189/2018-2023-global-pituitary-cancer-market-report-status-n-outlook_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pituitary cancer market for 2018-2023.
Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
Over the next five years, LPI(LP Information) projects that Pituitary cancer will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Pituitary cancer market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pituitary cancer market for 2018-2023.
Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
Over the next five years, LPI(LP Information) projects that Pituitary cancer will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Pituitary cancer market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
- Blood Tests
- Urine Test
- Vision Testing
- Hospital
- Clinics
- Diagnostic Centers
- Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Trinity Biotech
- Salzman
- Genentech
- Sigma-Aldrich
- Varian Medical Systems
- Elekta
- Accuray Incorporated
- Ion Beam Applications
- Nordion
- C. R. Bard
- Isoray Medical
- RaySearch Laboratories
- Mevion Medical Systems
- Mitsubishi Electric
Research objectives
- To study and analyze the global Pituitary cancer market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Pituitary cancer market by identifying its various subsegments.
- Focuses on the key global Pituitary cancer players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Pituitary cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the size of Pituitary cancer submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pituitary cancer Market Size 2013-2023
2.1.2 Pituitary cancer Market Size CAGR by Region
2.2 Pituitary cancer Segment by Type
2.2.1 Blood Tests
2.2.2 Urine Test
2.2.3 Brain Imaging
2.2.4 Vision Testing
2.3 Pituitary cancer Market Size by Type
2.3.1 Global Pituitary cancer Market Size Market Share by Type (2013-2018)
2.3.2 Global Pituitary cancer Market Size Growth Rate by Type (2013-2018)
2.4 Pituitary cancer Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Diagnostic Centers
2.4.4 Research Institutes
2.5 Pituitary cancer Market Size by Application
2.5.1 Global Pituitary cancer Market Size Market Share by Application (2013-2018)
2.5.2 Global Pituitary cancer Market Size Growth Rate by Application (2013-2018)
3 GLOBAL PITUITARY CANCER BY PLAYERS
3.1 Global Pituitary cancer Market Size Market Share by Players
3.1.1 Global Pituitary cancer Market Size by Players (2016-2018)
3.1.2 Global Pituitary cancer Market Size Market Share by Players (2016-2018)
3.2 Global Pituitary cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PITUITARY CANCER BY REGIONS
4.1 Pituitary cancer Market Size by Regions
4.2 Americas Pituitary cancer Market Size Growth
4.3 APAC Pituitary cancer Market Size Growth
4.4 Europe Pituitary cancer Market Size Growth
4.5 Middle East & Africa Pituitary cancer Market Size Growth
5 AMERICAS
5.1 Americas Pituitary cancer Market Size by Countries
5.2 Americas Pituitary cancer Market Size by Type
5.3 Americas Pituitary cancer Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pituitary cancer Market Size by Countries
6.2 APAC Pituitary cancer Market Size by Type
6.3 APAC Pituitary cancer Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Pituitary cancer by Countries
7.2 Europe Pituitary cancer Market Size by Type
7.3 Europe Pituitary cancer Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pituitary cancer by Countries
8.2 Middle East & Africa Pituitary cancer Market Size by Type
8.3 Middle East & Africa Pituitary cancer Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL PITUITARY CANCER MARKET FORECAST
10.1 Global Pituitary cancer Market Size Forecast (2018-2023)
10.2 Global Pituitary cancer Forecast by Regions
10.2.1 Global Pituitary cancer Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pituitary cancer Forecast by Type
10.8 Global Pituitary cancer Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Trinity Biotech
11.1.1 Company Details
11.1.2 Pituitary cancer Product Offered
11.1.3 Trinity Biotech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Trinity Biotech News
11.2 Salzman
11.2.1 Company Details
11.2.2 Pituitary cancer Product Offered
11.2.3 Salzman Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Salzman News
11.3 Genentech
11.3.1 Company Details
11.3.2 Pituitary cancer Product Offered
11.3.3 Genentech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Genentech News
11.4 Sigma-Aldrich
11.4.1 Company Details
11.4.2 Pituitary cancer Product Offered
11.4.3 Sigma-Aldrich Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Sigma-Aldrich News
11.5 Varian Medical Systems
11.5.1 Company Details
11.5.2 Pituitary cancer Product Offered
11.5.3 Varian Medical Systems Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Varian Medical Systems News
11.6 Elekta
11.6.1 Company Details
11.6.2 Pituitary cancer Product Offered
11.6.3 Elekta Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Elekta News
11.7 Accuray Incorporated
11.7.1 Company Details
11.7.2 Pituitary cancer Product Offered
11.7.3 Accuray Incorporated Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Accuray Incorporated News
11.8 Ion Beam Applications
11.8.1 Company Details
11.8.2 Pituitary cancer Product Offered
11.8.3 Ion Beam Applications Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Ion Beam Applications News
11.9 Nordion
11.9.1 Company Details
11.9.2 Pituitary cancer Product Offered
11.9.3 Nordion Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Nordion News
11.10 C. R. Bard
11.10.1 Company Details
11.10.2 Pituitary cancer Product Offered
11.10.3 C. R. Bard Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 C. R. Bard News
11.11 Isoray Medical
11.12 RaySearch Laboratories
11.13 Mevion Medical Systems
11.14 Mitsubishi Electric
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pituitary cancer Market Size 2013-2023
2.1.2 Pituitary cancer Market Size CAGR by Region
2.2 Pituitary cancer Segment by Type
2.2.1 Blood Tests
2.2.2 Urine Test
2.2.3 Brain Imaging
2.2.4 Vision Testing
2.3 Pituitary cancer Market Size by Type
2.3.1 Global Pituitary cancer Market Size Market Share by Type (2013-2018)
2.3.2 Global Pituitary cancer Market Size Growth Rate by Type (2013-2018)
2.4 Pituitary cancer Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Diagnostic Centers
2.4.4 Research Institutes
2.5 Pituitary cancer Market Size by Application
2.5.1 Global Pituitary cancer Market Size Market Share by Application (2013-2018)
2.5.2 Global Pituitary cancer Market Size Growth Rate by Application (2013-2018)
3 GLOBAL PITUITARY CANCER BY PLAYERS
3.1 Global Pituitary cancer Market Size Market Share by Players
3.1.1 Global Pituitary cancer Market Size by Players (2016-2018)
3.1.2 Global Pituitary cancer Market Size Market Share by Players (2016-2018)
3.2 Global Pituitary cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PITUITARY CANCER BY REGIONS
4.1 Pituitary cancer Market Size by Regions
4.2 Americas Pituitary cancer Market Size Growth
4.3 APAC Pituitary cancer Market Size Growth
4.4 Europe Pituitary cancer Market Size Growth
4.5 Middle East & Africa Pituitary cancer Market Size Growth
5 AMERICAS
5.1 Americas Pituitary cancer Market Size by Countries
5.2 Americas Pituitary cancer Market Size by Type
5.3 Americas Pituitary cancer Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pituitary cancer Market Size by Countries
6.2 APAC Pituitary cancer Market Size by Type
6.3 APAC Pituitary cancer Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Pituitary cancer by Countries
7.2 Europe Pituitary cancer Market Size by Type
7.3 Europe Pituitary cancer Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pituitary cancer by Countries
8.2 Middle East & Africa Pituitary cancer Market Size by Type
8.3 Middle East & Africa Pituitary cancer Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL PITUITARY CANCER MARKET FORECAST
10.1 Global Pituitary cancer Market Size Forecast (2018-2023)
10.2 Global Pituitary cancer Forecast by Regions
10.2.1 Global Pituitary cancer Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pituitary cancer Forecast by Type
10.8 Global Pituitary cancer Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Trinity Biotech
11.1.1 Company Details
11.1.2 Pituitary cancer Product Offered
11.1.3 Trinity Biotech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Trinity Biotech News
11.2 Salzman
11.2.1 Company Details
11.2.2 Pituitary cancer Product Offered
11.2.3 Salzman Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Salzman News
11.3 Genentech
11.3.1 Company Details
11.3.2 Pituitary cancer Product Offered
11.3.3 Genentech Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Genentech News
11.4 Sigma-Aldrich
11.4.1 Company Details
11.4.2 Pituitary cancer Product Offered
11.4.3 Sigma-Aldrich Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Sigma-Aldrich News
11.5 Varian Medical Systems
11.5.1 Company Details
11.5.2 Pituitary cancer Product Offered
11.5.3 Varian Medical Systems Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Varian Medical Systems News
11.6 Elekta
11.6.1 Company Details
11.6.2 Pituitary cancer Product Offered
11.6.3 Elekta Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Elekta News
11.7 Accuray Incorporated
11.7.1 Company Details
11.7.2 Pituitary cancer Product Offered
11.7.3 Accuray Incorporated Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Accuray Incorporated News
11.8 Ion Beam Applications
11.8.1 Company Details
11.8.2 Pituitary cancer Product Offered
11.8.3 Ion Beam Applications Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Ion Beam Applications News
11.9 Nordion
11.9.1 Company Details
11.9.2 Pituitary cancer Product Offered
11.9.3 Nordion Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Nordion News
11.10 C. R. Bard
11.10.1 Company Details
11.10.2 Pituitary cancer Product Offered
11.10.3 C. R. Bard Pituitary cancer Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 C. R. Bard News
11.11 Isoray Medical
11.12 RaySearch Laboratories
11.13 Mevion Medical Systems
11.14 Mitsubishi Electric
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Table Product Specifications of Pituitary cancer
Figure Pituitary cancer Report Years Considered
Figure Market Research Methodology
Figure Global Pituitary cancer Market Size Growth Rate 2013-202
Table Product Specifications of Pituitary cancer
Figure Pituitary cancer Report Years Considered
Figure Market Research Methodology
Figure Global Pituitary cancer Market Size Growth Rate 2013-202